A Swedish trial found artificial intelligence in breast cancer screening cut later cancer diagnoses by 12% and boosted early detection.
Researchers studied 100,000 women in Sweden who underwent mammography between 2021 and 2022.
Women receiving AI-supported screening showed fewer cancers diagnosed after screening than those reviewed only by radiologists.
The AI system flagged high-risk cases and supported doctors by highlighting suspicious findings.
More than 80% of cancers in the AI group were detected early, compared with 74% in standard screening.
The study, published in The Lancet, suggests AI could ease radiologist workloads while improving detection.
Researchers stressed AI should support, not replace, human clinicians.
AI Breast Screening Cuts Later Cancer Diagnoses by 12%, Major Study Finds
OMN AI
This article was created with the assistance of OMN AI, the AI-powered editorial platform developed by OMN Group. Every article is reviewed, fact-checked, and approved by a human journalist before publication to ensure accuracy and editorial quality. Learn more at https://omngroup.com
